Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 36.7893.14298.54-62.910.46

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 36.78 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202536.78
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 36.78
-60.51
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,717.5 Cr -2.7% -3.7% -42.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,218.0 Cr -0.7% 3% -13.4% Stock Analytics
DIVIS LABORATORIES ₹175,158.0 Cr 1.9% 8.3% 5.8% Stock Analytics
CIPLA ₹126,710.0 Cr 0.5% 0.7% -2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,586.0 Cr -0.1% NA 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,496.0 Cr -2% -5.4% -7.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.7%

-3.7%

-42.2%

SENSEX

1.6%

2.1%

2.6%


You may also like the below Video Courses